Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
adolescents
children infants |
| gptkbp:alternativeTo |
gptkb:MenACWY_vaccine
|
| gptkbp:broadcastOn |
varies by country
|
| gptkbp:contains |
amino acid transporter
polysaccharide antigen |
| gptkbp:contraindication |
severe allergic reaction to previous dose
|
| https://www.w3.org/2000/01/rdf-schema#label |
MenC vaccine
|
| gptkbp:introducedIn |
1999
|
| gptkbp:prevention |
meningococcal group C disease
|
| gptkbp:reduces |
carriage of Neisseria meningitidis group C
incidence of meningococcal C disease |
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
fever
swelling at injection site irritability redness at injection site |
| gptkbp:target |
gptkb:Neisseria_meningitidis_group_C
|
| gptkbp:type |
vaccine
|
| gptkbp:usedIn |
gptkb:Australia
gptkb:Canada gptkb:Ireland gptkb:United_Kingdom |
| gptkbp:WHOStatus |
recommended in some countries
|
| gptkbp:bfsParent |
gptkb:Neisseria_meningitidis_serogroup_C
gptkb:Neisseria_meningitidis_group_C |
| gptkbp:bfsLayer |
7
|